ArticleExperimental and therapeutic medicine2018

TASK-1 induces gefitinib resistance by promoting cancer initiating cell formation and epithelial-mesenchymal transition in lung cancer.

Xing-Guang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.